BPC-157 vs Epigen

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

BPC-157

Body Protection Compound-157 is a synthetic peptide derived from a protein found in human gastric juice. It has shown remarkable healing properties in research studies.

Full details →

Epigen

Epigen is a member of the epidermal growth factor (EGF) family. It plays roles in skin regeneration and has been studied for wound healing and anti-aging applications.

Full details →

Side-by-Side Comparison

Aspect	BPC-157	Epigen
Dose Range	250 mcg–500 mcg	100 mcg–500 mcg
Frequency	2x daily	1x daily
Cycle Length	4–6 weeks	4–8 weeks
Route	subcutaneous	subcutaneous
Mechanism	BPC-157 works through multiple pathways including upregulation of growth factor expression, nitric oxide system modulation, and promotion of angiogenesis. It enhances tendon-to-bone healing and supports the formation of new blood vessels.	Binds to and activates the EGF receptor (EGFR), promoting cell proliferation, migration, and differentiation. Involved in skin homeostasis and repair processes.
Typical Dosage	Typical research dosages range from 250-500mcg administered 1-2 times daily. Both subcutaneous and oral administration have been studied.	Topical: Typically used at low concentrations (ppm to low %) in cosmetic formulations. Research applications vary.
Administration	Can be administered subcutaneously near the injury site or systemically. Stable in gastric juice, making oral administration viable.	Primarily topical application for skincare. Research may use other routes for systemic effects.
Side Effects	Generally well-tolerated in research. Some reports of mild nausea or dizziness at higher doses.	Topical use generally well-tolerated. Theoretical concerns about promoting cell proliferation.
Best For	Muscle Growth Recovery & Healing	Recovery & Healing Skin Health & Aesthetics